Osteoarthritis of the Hip or Knee
- December 11, 2015
The purpose of this research study is to evaluate the long-term safety and effectiveness of an investigational medication in subjects with osteoarthritis of the hip or knee.
Duration: Approximately 21 months
Number of visits to CKRA: At least 15
Reimbursement for Travel Expenses: Up to $560 for completion
Note: Qualified participants must be at least 18 years old who have been diagnosed with osteoarthritis of the hip or knee, and be taking naproxen, celecoxib, or diclofenac for hip or knee pain at least 5 days per week. Other criteria also apply.